These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 27849590)
1. Nanoparticle engineered TRAIL-overexpressing adipose-derived stem cells target and eradicate glioblastoma via intracranial delivery. Jiang X; Fitch S; Wang C; Wilson C; Li J; Grant GA; Yang F Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13857-13862. PubMed ID: 27849590 [TBL] [Abstract][Full Text] [Related]
2. Targeting Tumor Hypoxia Using Nanoparticle-engineered CXCR4-overexpressing Adipose-derived Stem Cells. Jiang X; Wang C; Fitch S; Yang F Theranostics; 2018; 8(5):1350-1360. PubMed ID: 29507625 [TBL] [Abstract][Full Text] [Related]
3. Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells. Zhang X; Zhang X; Hu S; Zheng M; Zhang J; Zhao J; Zhang X; Yan B; Jia L; Zhao J; Wu K; Yang A; Zhang R Nucleic Acids Res; 2017 Jun; 45(10):5930-5944. PubMed ID: 28459998 [TBL] [Abstract][Full Text] [Related]
4. Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors. Redjal N; Zhu Y; Shah K Stem Cells; 2015 Jan; 33(1):101-10. PubMed ID: 25186100 [TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma. Wang K; Kievit FM; Jeon M; Silber JR; Ellenbogen RG; Zhang M Adv Healthc Mater; 2015 Dec; 4(17):2719-26. PubMed ID: 26498165 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138 [TBL] [Abstract][Full Text] [Related]
7. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [TBL] [Abstract][Full Text] [Related]
9. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma. Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058 [TBL] [Abstract][Full Text] [Related]
10. TRAIL-engineered bone marrow-derived mesenchymal stem cells: TRAIL expression and cytotoxic effects on C6 glioma cells. Tang XJ; Lu JT; Tu HJ; Huang KM; Fu R; Cao G; Huang M; Cheng LH; Dai LJ; Zhang L Anticancer Res; 2014 Feb; 34(2):729-34. PubMed ID: 24511006 [TBL] [Abstract][Full Text] [Related]
11. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma. Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508 [TBL] [Abstract][Full Text] [Related]
13. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models. Wohlfahrt ME; Beard BC; Lieber A; Kiem HP Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719 [TBL] [Abstract][Full Text] [Related]
14. Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Kauer TM; Figueiredo JL; Hingtgen S; Shah K Nat Neurosci; 2011 Dec; 15(2):197-204. PubMed ID: 22197831 [TBL] [Abstract][Full Text] [Related]
15. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma. Xia L; Peng R; Leng W; Jia R; Zeng X; Yang X; Fan M J Dent Res; 2015 Jan; 94(1):219-28. PubMed ID: 25391621 [TBL] [Abstract][Full Text] [Related]
16. TRAIL-overexpressing Adipose Tissue-derived Mesenchymal Stem Cells Efficiently Inhibit Tumor Growth in an H460 Xenograft Model. Un Choi Y; Yoon Y; Jung PY; Hwang S; Hong JE; Kim WS; Sohn JH; Rhee KJ; Bae KS; Eom YW Cancer Genomics Proteomics; 2021; 18(4):569-578. PubMed ID: 34183389 [TBL] [Abstract][Full Text] [Related]
17. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes. Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors. Martinez-Quintanilla J; Bhere D; Heidari P; He D; Mahmood U; Shah K Stem Cells; 2013 Aug; 31(8):1706-14. PubMed ID: 23389839 [TBL] [Abstract][Full Text] [Related]
19. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells. Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125 [TBL] [Abstract][Full Text] [Related]
20. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. Bagó JR; Okolie O; Dumitru R; Ewend MG; Parker JS; Werff RV; Underhill TM; Schmid RS; Miller CR; Hingtgen SD Sci Transl Med; 2017 Feb; 9(375):. PubMed ID: 28148846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]